Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Papaverine in First Stage of Labor
NCT02362139Phase 3Unknown
- Start
- Feb 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of papaverine in labor (2 arms). Primary endpoint: The duration of time between Papaverine administration and delivery at 24 month. Status: unknown.
02
Drugs
papaverine
03
Conditions
labor
Beyond the preview
Go deeper on NCT02362139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02362139.